Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001137050-14-000170
Filing Date
2014-08-13
Accepted
2014-08-13 14:07:47
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 antiviral10q20140630final.htm 10-Q 359255
2 exhibit311.htm EX-31 6051
3 exhibit312.htm EX-31 6080
4 exhibit321.htm EX-32 2175
5 exhibit322.htm EX-32 2190
  Complete submission text file 0001137050-14-000170.txt   2475118

Data Files

Seq Description Document Type Size
6 avrt-20140630.xml EX-101.INS 358579
7 avrt-20140630.xsd EX-101.SCH 24904
8 avrt-20140630_lab.xml EX-101.LAB 108347
9 avrt-20140630_pre.xml EX-101.PRE 105074
10 avrt-20140630_cal.xml EX-101.CAL 6333
11 avrt-20140630_def.xml EX-101.DEF 33881
Mailing Address SUITE 1211, TOWER 2, SILVERCORD 30 CANTON ROAD, TSIMSHATSUI KOWLOON K3 00000
Business Address SUITE 1211, TOWER 2, SILVERCORD 30 CANTON ROAD, TSIMSHATSUI KOWLOON K3 00000 852-2317-1291
ANTIVIRAL TECHNOLOGIES, INC. (Filer) CIK: 0001445226 (see all company filings)

EIN.: 261188469 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53449 | Film No.: 141036939
SIC: 6770 Blank Checks